A detailed history of Teacher Retirement System Of Texas transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 24,890 shares of VKTX stock, worth $1.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,890
Previous 21,614 15.16%
Holding current value
$1.31 Million
Previous $1.15 Million 37.43%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$49.84 - $70.47 $163,275 - $230,859
3,276 Added 15.16%
24,890 $1.58 Million
Q2 2024

Aug 09, 2024

BUY
$47.39 - $80.2 $127,526 - $215,818
2,691 Added 14.22%
21,614 $1.15 Million
Q1 2024

May 06, 2024

SELL
$17.4 - $94.5 $17,278 - $93,838
-993 Reduced 4.99%
18,923 $1.55 Million
Q4 2023

Feb 07, 2024

SELL
$9.24 - $19.64 $55,190 - $117,309
-5,973 Reduced 23.07%
19,916 $371,000
Q3 2023

Oct 31, 2023

BUY
$10.92 - $16.0 $2,446 - $3,584
224 Added 0.87%
25,889 $287,000
Q2 2023

Jul 19, 2023

BUY
$14.84 - $24.79 $65,340 - $109,150
4,403 Added 20.71%
25,665 $416,000
Q1 2023

May 12, 2023

BUY
$8.08 - $17.33 $171,796 - $368,470
21,262 New
21,262 $354,000
Q2 2022

Aug 09, 2022

SELL
$2.11 - $3.15 $8,256 - $12,325
-3,913 Reduced 26.84%
10,667 $31,000
Q1 2022

May 09, 2022

BUY
$3.0 - $4.88 $2,481 - $4,035
827 Added 6.01%
14,580 $44,000
Q4 2021

Feb 10, 2022

BUY
$4.6 - $6.72 $14,420 - $21,067
3,135 Added 29.53%
13,753 $63,000
Q3 2021

Nov 09, 2021

BUY
$5.58 - $7.04 $59,248 - $74,750
10,618 New
10,618 $67,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.